UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): March 1, 2010
(Exact
name of registrant as specified in its charter)
|
Delaware
|
0-21121
|
06-1456680
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
file number)
|
(I.R.S.
employer identification no.)
|
|
One
Hamden Center
|
|
|
2319
Whitney Ave, Suite 3B, Hamden, CT
|
06518
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (203) 859-6800
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240-14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item
5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On March
1, 2010, the Board of Directors of TransAct Technologies Incorporated
(“TransAct”) designated Christopher Galletta, 32, as its principal accounting
officer. Mr. Galletta has served as TransAct’s Corporate Controller
since October 15, 2007 and prior to that he served as TransAct’s Assistant
Corporate Controller from when he joined TransAct in June
2005. Between September 2000 and April 2005, Mr. Galletta was
employed by PricewaterhouseCoopers LLP, an independent public accounting firm,
most recently as a senior associate in the technology audit practice, during
which time Mr. Galletta managed the audits of both public and private
corporations in the software, manufacturing and biotechnology
sectors.
Prior to
the designation of Mr. Galletta, the responsibilities of principal accounting
officer were performed by Steven A. DeMartino, TransAct’s Executive Vice
President, Chief Financial Officer, Treasurer and Secretary. Mr.
DeMartino continues to serve as TransAct’s Chief Financial Officer and principal
financial officer.
2
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
TRANSACT
TECHNOLOGIES INCORPORATED
|
||||
|
By:
|
/s/
Steven A. DeMartino
|
|||
|
Steven
A. DeMartino
|
||||
|
Executive
Vice President, Chief Financial Officer, Treasurer and
Secretary
|
||||
Date:
March 4, 2010
3